It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
To investigate whether earlier “post-term” monitoring of South Asian (SA) pregnancies from 39 weeks’ gestation with amniotic fluid index (AFI) and cardiotocography (CTG) detected suspected fetal compromise. Retrospective cohort study of all SA-born women at an Australian health service with uncomplicated, singleton pregnancies following the introduction of twice-weekly AFI and CTG monitoring from 39 weeks. Monitoring results, and their association with a perinatal compromise composite (including assisted delivery for fetal compromise, stillbirth, and NICU admission) were determined. 771 SA-born women had earlier monitoring, triggering delivery in 82 (10.6%). 31 (4%) had a non-reassuring antepartum CTG (abnormal fetal heart rate or variability, or decelerations) and 21 (2.7%) had an abnormal AFI (≤ 5 cm). Women with abnormal monitoring were 53% (95% CI 1.2–1.9) more likely to experience perinatal compromise and 83% (95% CI 1.2–2.9) more likely to experience intrapartum compromise than women with normal monitoring. Monitoring from 39 weeks identified possible fetal compromise earlier than it otherwise would have been, and triggered intervention in 10% of women. Without robust evidence to guide timing of birth in SA-born women to reduce rates of stillbirth, earlier monitoring provides an alternative to routine induction of labour.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Hudson Institute of Medical Research, The Ritchie Centre, Clayton, Australia (GRID:grid.452824.d); Monash University, Department of Obstetrics and Gynaecology, Clayton, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857)
2 Monash University, Department of Obstetrics and Gynaecology, Clayton, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857); Monash Health, Clayton, Australia (GRID:grid.419789.a) (ISNI:0000 0000 9295 3933)
3 Monash University, Department of Obstetrics and Gynaecology, Clayton, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857); Safer Care Victoria, Melbourne, Australia (GRID:grid.1002.3)
4 Monash University, Department of Obstetrics and Gynaecology, Clayton, Australia (GRID:grid.1002.3) (ISNI:0000 0004 1936 7857)
5 Hudson Institute of Medical Research, The Ritchie Centre, Clayton, Australia (GRID:grid.452824.d); Centre of Research Excellence in Stillbirth, Brisbane, Australia (GRID:grid.452824.d)